Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Audrey Nadalini

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
ACS Applied Materials & Interfaces|April 23, 2024
Microfluidic-SERS Technologies for CTC: A Perspective on Clinical TranslationAmin Hassanzadeh-Barforoushi, Anastasiia Tukova, Audrey Nadalini, et al.
ACS Sensors|March 12, 2026
A SERRS-Based Lateral Flow Assay for Sensitive Detection of Mitochondrial DNA in Endometriosis ScreeningLaura M Rey Gomez, Kazi Morshed Alom, Audrey Nadalini, et al.
Nature Communications|August 6, 2022
Temporal profiling of the breast tumour microenvironment reveals collagen XII as a driver of metastasisMichael Papanicolaou, Amelia L Parker, Michelle Yam, et al.
Nature Cancer|August 28, 2023
A first-in-class pan-lysyl oxidase inhibitor impairs stromal remodeling and enhances gemcitabine response and survival in pancreatic cancerJessica L Chitty, Michelle Yam, Lara Perryman, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
ACS Applied Materials & Interfaces|April 23, 2024
Microfluidic-SERS Technologies for CTC: A Perspective on Clinical TranslationAmin Hassanzadeh-Barforoushi, Anastasiia Tukova, Audrey Nadalini, et al.
ACS Sensors|March 12, 2026
A SERRS-Based Lateral Flow Assay for Sensitive Detection of Mitochondrial DNA in Endometriosis ScreeningLaura M Rey Gomez, Kazi Morshed Alom, Audrey Nadalini, et al.
Nature Communications|August 6, 2022
Temporal profiling of the breast tumour microenvironment reveals collagen XII as a driver of metastasisMichael Papanicolaou, Amelia L Parker, Michelle Yam, et al.
Nature Cancer|August 28, 2023
A first-in-class pan-lysyl oxidase inhibitor impairs stromal remodeling and enhances gemcitabine response and survival in pancreatic cancerJessica L Chitty, Michelle Yam, Lara Perryman, et al.
Pageof 1